Our study demonstrated that SNHG3/miR-330 signaling axis regulated the proliferation and metabolism of breast tumor cells through modulating PKM at the post-transcription level, providing potential therapeutic targets for inhibiting PKM in cancer treatment. This evidence concerns the gene SNHG3 and breast neoplasm.